IMV Inc. to Present at Upcoming Investor Conferences
09 October 2018 - 10:05PM
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology
corporation, today announced that Chief Executive Officer Frederic
Ors and Chief Financial Officer Pierre Labbé will present a
corporate update at two upcoming investor conferences.
BIO Investor Forum, San Francisco, CA
- Date: Thursday, October 18, 2018
- Time: 9:00 a.m. PT
- Location: The Elizabeth Room, Westin St.
Francis
- A live webcast of the presentation will be accessible via the
following URL:
http://www.veracast.com/webcasts/bio/investorforum2018/15132412139.cfm.
Dawson James Small Cap Growth Conference, Jupiter, FL
- Date: Tuesday, October 30, 2018
- Time: 10:30 a.m. ET
- Location: Track 2 - Preserve Ballroom B,
Wyndham Grand Jupiter Hotel
- A live webcast of the presentation will be accessible via the
following URL: http://wsw.com/webcast/dawson4/imv/.
Both webcasts will be archived for 90 days following the live
presentation. A copy of the presentations will also be available on
the Events, Webcasts & Presentations page of IMV’s website:
www.imv-inc.com.
About IMV
IMV Inc., formerly Immunovaccine Inc., is a clinical
stage biopharmaceutical company dedicated to making immunotherapy
more effective, more broadly applicable, and more widely available
to people facing cancer and other serious diseases. IMV is
pioneering a new class of immunotherapies based on the Company’s
proprietary drug delivery platform. This patented technology
leverages a novel mechanism of action that enables the programming
of immune cells in vivo, which are aimed at generating
powerful new synthetic therapeutic capabilities. IMV’s lead
candidate, DPX-Survivac, is a T cell-activating immunotherapy that
combines the utility of the platform with a target: survivin. IMV
is currently assessing DPX-Survivac as a combination therapy in
multiple clinical studies with Incyte and Merck. Connect
at www.imv-inc.com.
Contacts for
IMV:MEDIA Mike Beyer, Sam
Brown Inc.T: (312) 961-2502 E: mikebeyer@sambrown.com
INVESTOR RELATIONSPierre Labbé, Chief
Financial OfficerT: (902) 492-1819 E: info@imv-inc.com
Patti Bank, Managing Director, Westwicke
PartnersO: (415) 513-1284T: (415) 515-4572 E:
patti.bank@westwicke.com
IMV (TSX:IMV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMV (TSX:IMV)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about IMV Inc (Toronto Stock Exchange): 0 recent articles
More News Articles